Industries > Pharma > Synthetic Biology Market Report 2021-2031
Synthetic Biology Market Report 2021-2031
By Product Type (Oligonucleotides, Enzymes, Cloning Technology Kits, Synthetic Cells, Synthetic Genes, Synthetic DNA, Synthetic Clones, Chassis Organisms, Xeno-Nucleic Acids, and Others), By Technology (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mutagenesis, Measurement & Modeling, Microfluidics, Nanotechnology, and Others), By Application (Medical Applications, Pharmaceuticals, Industrial Applications, Food & Agriculture, Environmental Applications, and Others), By Patient Demographics (Adults, Geriatric, and Pediatric), By Distribution Channel (Direct Tender, Retail Sales), and Leading Regional/ Country market analysis
Synthetic Biology Market– our new study reveals trends, R&D progress, and predicted revenues
Where the Synthetic Biology is market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our 300+ page report provides 420+ tables and 400+ charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Synthetic Biology Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
• Revenue and growth forecasts from 2021 to 2031 for the Global Synthetic Biology Market By Product Type
• Oligonucleotides
• Enzymes
• Cloning Technology Kits
• Synthetic Cells
• Synthetic Genes
• Synthetic DNA
• Synthetic Clones
• Chassis Organisms
• Xeno-Nucleic Acids
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Synthetic Biology Market By Technology
• Gene Synthesis
• Genome Engineering
• Sequencing
• Bioinformatics
• Cloning
• Site-Directed Mutagenesis
• Measurement & Modeling
• Microfluidics
• Nanotechnology
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Synthetic Biology Market By Application
• Medical Applications
• Pharmaceuticals
o Drug Discovery and Therapeutics
Cancer Detection & Diagnostics
Other Drug Discovery and Therapeutic Applications
o Artificial Tissue & Tissue Regeneration
Bio-Synthesis
Stem Cell Regulation
Other Artificial Tissue and Tissue Regeneration Applications
• Industrial Applications
o Biofuel and Renewable Energy
o Industrial Enzymes
Textile Industry
Paper Industry
Other Industries
o Biomaterials & Green Chemicals
• Food & Agriculture
• Environmental Applications
o Bioremediation
o Biosensing
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Synthetic Biology Market By Patient Demographics
• Adults
• Geriatric
• Pediatric
• Revenue and growth forecasts from 2021 to 2031 for the Global Synthetic Biology Market By Distribution Channel
• Direct Tender
• Retail Sales
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Synthetic Biology Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Synthetic Biology Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Synthetic Biology Market report helps you
In summary, our 300+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Synthetic Biology Market, with forecasts for Get our report today Synthetic Biology Market Forecast 2021-2031: By Product Type, Technology, Application, Patient Demographics, By End User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Synthetic Biology market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Synthetic Biology Market. Some of the company’s profiled in this report include
• Thermo Fisher Scientific, Inc.
• Merck Kgaa
• Agilent Technologies, Inc.
• Novozymes A/S
• Ginkgo Bioworks
• Amyris, Inc.
• Intrexon Corporation
• Genscript Biotech Corporation
• Twist Bioscience
• Synthetic Genomics, Inc. (SGI)
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Synthetic Biology Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Synthetic Biology Market Report 2021-2031: By Product Type (Oligonucleotides, Enzymes, Cloning Technology Kits, Synthetic Cells, Synthetic Genes, Synthetic DNA, Synthetic Clones, Chassis Organisms, Xeno-Nucleic Acids, and Others), By Technology (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mutagenesis, Measurement & Modeling, Microfluidics, Nanotechnology, and Others), By Application (Medical Applications, Pharmaceuticals, Industrial Applications, Food & Agriculture, Environmental Applications, and Others), By Patient Demographics (Adults, Geriatric, and Pediatric), By Distribution Channel (Direct Tender, Retail Sales), and Leading Regional/ Country market analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Synthetic Biology Market
2.1. Synthetic Biology Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Synthetic Biology Market Overview
3.1. Global Synthetic Biology Market Size and Forecast By Region
3.2. Global Synthetic Biology Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising funding and growing initiatives in synthetic biology
3.3.1.2. Rapid surge in the synthetic biology demand in medical applications, pharmaceuticals industry
3.3.1.3. Increasing geriatric population around the world
3.3.1.4. Increasing strategic initiatives in synthetic biology market
3.3.2. Market Restraints
3.3.2.1. Product recall
3.3.2.2. High cost of synthetic biology product
3.3.3. Opportunities
3.3.3.1. Increasing research in synthetic drugs and vaccines
3.3.3.2. Opportunity 2
3.3.3.3. Opportunity 3
3.3.4. Challenges
3.3.4.1. Stringent regulation
3.3.4.2. Increasing environment concerns around the world
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Synthetic Biology Market Analysis and Forecast 2021-2031, By Product Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Oligonucleotides
4.1.1.1. Oligonucleotides market size and forecast, 2021-2031 (USD Million)
4.1.2. Enzymes
4.1.2.1. Enzymes market size and forecast, 2021-2031 (USD Million)
4.1.3. Cloning Technology Kits
4.1.3.1. Cloning Technology Kits market size and forecast, 2021-2031 (USD Million)
4.1.4. Synthetic Cells
4.1.4.1. Synthetic Cells market size and forecast, 2021-2031 (USD Million)
4.1.5. Synthetic Genes
4.1.5.1. Synthetic Genes market size and forecast, 2021-2031 (USD Million)
4.1.6. Synthetic DNA
4.1.6.1. Synthetic DNA market size and forecast, 2021-2031 (USD Million)
4.1.7. Synthetic Clones
4.1.7.1. Synthetic Clones market size and forecast, 2021-2031 (USD Million)
4.1.8. Chassis Organisms
4.1.8.1. Chassis Organisms market size and forecast, 2021-2031 (USD Million)
4.1.9. Xeno-Nucleic Acids
4.1.9.1. Xeno-Nucleic Acids market size and forecast, 2021-2031 (USD Million)
4.1.10. Others
4.1.10.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Synthetic Biology Market Analysis and Forecast, 2021-2031 By Technology (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Gene Synthesis
5.1.1.1. Gene Synthesis market size and forecast, 2021-2031 (USD Million)
5.1.2. Genome Engineering
5.1.2.1. Genome Engineering market size and forecast, 2021-2031 (USD Million)
5.1.3. Sequencing
5.1.3.1. Sequencing Market size and forecast, 2021-2031 (USD Million)
5.1.4. Bioinformatics
5.1.4.1. Bioinformatics Market size and forecast, 2021-2031 (USD Million)
5.1.5. Cloning
5.1.5.1. Cloning Market size and forecast, 2021-2031 (USD Million)
5.1.6. Site-Directed Mutagenesis
5.1.6.1. Site-Directed Mutagenesis size and forecast, 2021-2031 (USD Million)
5.1.7. Measurement & Modeling
5.1.7.1. Measurement & Modeling market size and forecast, 2021-2031 (USD Million)
5.1.8. Microfluidics
5.1.8.1. microfluidics market size and forecast, 2021-2031 (USD Million)
5.1.9. Nanotechnology
5.1.9.1. nanotechnology market size and forecast, 2021-2031 (USD Million)
5.1.10. Others
5.1.10.1. Others market size and forecast, 2021-2031 (USD Million)
6. Global Synthetic Biology Market Analysis and Forecast, 2021-2031 By Patient Demographics (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Geriatric
6.1.1.1. Geriatric market size and forecast, 2021-2031 (USD Million)
6.1.2. Adult
6.1.2.1. Adult market size and forecast, 2021-2031 (USD Million)
6.1.3. Pediatric
6.1.3.1. Pediatric market size and forecast, 2021-2031 (USD Million)
7. Global Synthetic Biology Market Analysis and Forecast, 2021-2031 By Application (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Medical Applications
7.1.1.1. Medical Applications market size and forecast, 2021-2031 (USD Million)
7.1.2. Pharmaceuticals
7.1.2.1. Pharmaceuticals market size and forecast, 2021-2031 (USD Million)
7.1.3. Industrial Applications
7.1.3.1. Industrial Applications market size and forecast, 2021-2031 (USD Million)
7.1.4. Food & Agriculture
7.1.4.1. Food & Agriculture market size and forecast, 2021-2031 (USD Million)
7.1.5. Environmental Applications
7.1.5.1. Environmental Applications market size and forecast, 2021-2031 (USD Million)
7.1.6. Others
7.1.6.1. Others market size and forecast, 2021-2031 (USD Million)
8. Global Synthetic Biology Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Direct Tender
8.1.1.1. Direct Tender market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Sales
8.1.2.1. Retail Sales market size and forecast, 2021-2031 (USD Million)
9. North America Synthetic Biology Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Synthetic Biology Market Size and Forecast By Product Type
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Synthetic Biology Market Size and Forecast By Technology
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Synthetic Biology Market Size and Forecast By Application
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Synthetic Biology Market Size and Forecast By Patient Demographics
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Synthetic Biology Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Synthetic Biology Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Synthetic Biology Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Synthetic Biology Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Synthetic Biology Market Size and Forecast By Product Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Synthetic Biology Market Size and Forecast By Technology
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Synthetic Biology Market Size and Forecast By Patient Demographics
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Synthetic Biology Market Size and Forecast By Application
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Synthetic Biology Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Synthetic Biology Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Synthetic Biology Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Synthetic Biology Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Synthetic Biology Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Synthetic Biology Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Synthetic Biology Market Size and Forecast By Product Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Synthetic Biology Market Size and Forecast By Technology
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Synthetic Biology Market Size and Forecast By Patient Demographics
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Synthetic Biology Market Size and Forecast By Application
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Synthetic Biology Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Synthetic Biology Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Synthetic Biology Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Synthetic Biology Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Synthetic Biology Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Synthetic Biology Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Synthetic Biology Market Size and Forecast By Product Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Synthetic Biology Market Size and Forecast By Technology
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Synthetic Biology Market Size and Forecast By Patient Demographics
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Synthetic Biology Market Size and Forecast By Application
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Synthetic Biology Market Size and Forecast By Distribution Channel
12.7. Brazil Synthetic Biology Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Synthetic Biology Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Synthetic Biology Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Synthetic Biology Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Synthetic Biology Market Size and Forecast By Product Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Synthetic Biology Market Size and Forecast By Technology
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Synthetic Biology Market Size and Forecast By Patient Demographics
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Synthetic Biology Market Size and Forecast By Application
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Synthetic Biology Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Synthetic Biology Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Synthetic Biology Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Synthetic Biology Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Synthetic Biology Market
14.1. Thermo Fisher Scientific, Inc.
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Merck Kgaa
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. Agilent Technologies, Inc.
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. Novozymes A/S
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. GINKGO BIOWORKS
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. Amyris, Inc.
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Intrexon Corporation
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. Genscript Biotech Corporation
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Twist Bioscience
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. Synthetic Genomics, Inc. (SGI)
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Synthetic Biology Market Drivers & Restraints 2021
Table 7. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 123. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 128. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 133. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 138. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 143. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 148. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 153. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 158. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 163. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 168. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 173. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 178. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 183. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 187. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 228. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 233. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 234. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 235. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 236. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 237. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 238. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 239. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 240. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 241. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 242. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 243. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 244. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 245. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 246. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 247. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 248. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 249. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 250. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 251. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 252. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 362. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 363. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 364. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 365. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 366. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 367. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 368. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 369. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 370. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 371. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 372. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 373. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 374. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 375. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 376. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 377. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 378. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 379. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 380. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 381. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 382. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 383. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 384. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 385. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 386. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 387. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 388. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 389. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 390. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 391. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 392. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 393. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 394. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 395. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 396. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 397. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 398. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 399. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 400. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 401. Leading 10 Synthetic Biology Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 402. Thermo Fisher Scientific, Inc.Profile 2019 (CEO, HQ, Founded, Website)
Table 403. Thermo Fisher Scientific, Inc. Synthetic Biology Product Offering (Segment, Product Offerings)
Table 404. Merck Kgaa Profile 2019 (CEO, HQ, Founded, Website)
Table 405. Merck Kgaa Synthetic Biology Product Offering (Segment, Product Offerings)
Table 406. Agilent Technologies, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 407. Agilent Technologies, Inc..Synthetic Biology Product Offering (Segment, Product Offerings)
Table 408. Novozymes A/S Profile 2019 (CEO, HQ, Founded, Website)
Table 409. Novozymes A/S Synthetic Biology Product Offering (Segment, Product Offerings)
Table 410. GINKGO BIOWORKS Profile 2019 (CEO, HQ, Founded, Website)
Table 411. GINKGO BIOWORKS Synthetic Biology Product Offering (Segment, Product Offerings)
Table 412. Amyris, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 413. Amyris, Inc. Synthetic Biology Product Offering (Segment, Product Offerings)
Table 414. Intrexon Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 415. Intrexon Corporation Synthetic Biology Product Offering (Segment, Product Offerings)
Table 416. Genscript Biotech Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 417. Genscript Biotech Corporation Synthetic Biology Product Offering (Segment, Product Offerings)
Table 418. Twist Bioscience Profile 2019 (CEO, HQ, Founded, Website)
Table 419. Twist Bioscience Synthetic Biology Product Offering (Segment, Product Offerings)
Table 420. Synthetic Genomics, Inc. (SGI) Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 421. Synthetic Genomics, Inc. (SGI) Synthetic Biology Product Offering (Segment, Product Offerings)
Table 422. Other Companies Involved in the Synthetic Biology Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Synthetic Biology Market Drivers & Restraints 2021
Figure 7. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 118. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 123. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 128. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 133. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 138. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 143. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 148. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 153. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 158. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 163. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 168. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 173. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 178. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 183. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 203. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 204. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 205. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 206. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 207. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 208. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 209. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 210. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 211. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 212. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 213. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 214. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 215. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 216. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 217. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 218. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 219. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 220. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 221. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 222. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 223. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 224. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 225. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 226. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 227. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 228. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 229. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 230. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 231. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 232. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 233. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 234. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 235. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 236. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 237. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 238. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 239. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 240. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 241. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 242. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 243. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 244. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 245. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 246. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 247. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 248. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 249. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 250. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 251. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 252. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 362. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 363. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 364. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 365. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 366. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 367. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 368. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 369. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 370. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 371. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 372. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 373. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 374. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 375. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 376. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 377. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 378. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 379. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 380. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 381. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 382. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 383. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 384. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 385. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 386. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 387. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 388. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 389. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 390. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 391. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 392. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 393. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 394. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 395. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 396. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 397. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 398. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 399. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 400. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 401. Porter’s Five Force Analysis
Companies Mentioned
1. Synthetic Genomics, Inc. (SGI)
2. Codexis, Inc.
3. Synthego Corporation
4. Creative Enzymes
5. Eurofins Scientific
6. Cyrus Biotechnology, Inc.
7. GlaxoSmithKline PLC
8. Biomarin Pharmaceutical Inc
9. Grifols SA
10. UCB SA
11. Eisai Co Ltd
12. Novo Nordisk A/S
13. Alexion Pharmaceuticals Inc
14. Takeda Pharmaceutical Co Ltd
15. Chugai Pharmaceutical Co Ltd
16. Perrigo Company PLC
17. Astellas Pharma Inc
18. Mitsubishi Tanabe Pharma Corp
19. Johnson & Johnson
20. Shanghai Fosun Pharmaceutical Group Co Ltd
21. Jiangsu Hengrui Medicine Co Ltd
22. Allergan plc
23. Shire PLC
24. Kyowa Hakko Kirin Co Ltd
25. Pfizer Inc
26. Taisho Pharmaceutical Holdings Co Ltd
27. MYL.O
28. Zoetis Inc
29. Bristol-Myers Squibb Co
30. Merck & Co Inc
31. AbbVie Inc
32. Jazz Pharmaceuticals PLC
33. Sumitomo Dainippon Pharma Co Ltd
34. AstraZeneca PLC
35. China Grand Automotive Services Co Ltd
36. Daiichi Sankyo Co Ltd
37. Novartis AG
38. Tasly Pharmaceutical Group Co Ltd
39. CSL Ltd
40. Biogen Inc
41. Orion Oyj
42. Bayer AG
43. CSPC Pharmaceutical Group Ltd
44. Sanofi SA
45. Roche Holding AG
46. Ono Pharmaceutical Co Ltd
47. Beijing Tongrentang Co Ltd
48. Kangmei Pharmaceutical Co Ltd
49. Ipsen SA
50. Abbott Laboratories
51. Shionogi & Co Ltd
52. Eli Lilly and Co
53. Recordati Industria Chimica e Farmaceutica SpA
54. Hikma Pharmaceuticals PLC
55. Teva Pharmaceutical Industries Ltd
56. Merck KGaA
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Synthetic Biology Market
2.1. Synthetic Biology Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Synthetic Biology Market Overview
3.1. Global Synthetic Biology Market Size and Forecast By Region
3.2. Global Synthetic Biology Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising funding and growing initiatives in synthetic biology
3.3.1.2. Rapid surge in the synthetic biology demand in medical applications, pharmaceuticals industry
3.3.1.3. Increasing geriatric population around the world
3.3.1.4. Increasing strategic initiatives in synthetic biology market
3.3.2. Market Restraints
3.3.2.1. Product recall
3.3.2.2. High cost of synthetic biology product
3.3.3. Opportunities
3.3.3.1. Increasing research in synthetic drugs and vaccines
3.3.3.2. Opportunity 2
3.3.3.3. Opportunity 3
3.3.4. Challenges
3.3.4.1. Stringent regulation
3.3.4.2. Increasing environment concerns around the world
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Synthetic Biology Market Analysis and Forecast 2021-2031, By Product Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Oligonucleotides
4.1.1.1. Oligonucleotides market size and forecast, 2021-2031 (USD Million)
4.1.2. Enzymes
4.1.2.1. Enzymes market size and forecast, 2021-2031 (USD Million)
4.1.3. Cloning Technology Kits
4.1.3.1. Cloning Technology Kits market size and forecast, 2021-2031 (USD Million)
4.1.4. Synthetic Cells
4.1.4.1. Synthetic Cells market size and forecast, 2021-2031 (USD Million)
4.1.5. Synthetic Genes
4.1.5.1. Synthetic Genes market size and forecast, 2021-2031 (USD Million)
4.1.6. Synthetic DNA
4.1.6.1. Synthetic DNA market size and forecast, 2021-2031 (USD Million)
4.1.7. Synthetic Clones
4.1.7.1. Synthetic Clones market size and forecast, 2021-2031 (USD Million)
4.1.8. Chassis Organisms
4.1.8.1. Chassis Organisms market size and forecast, 2021-2031 (USD Million)
4.1.9. Xeno-Nucleic Acids
4.1.9.1. Xeno-Nucleic Acids market size and forecast, 2021-2031 (USD Million)
4.1.10. Others
4.1.10.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Synthetic Biology Market Analysis and Forecast, 2021-2031 By Technology (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Gene Synthesis
5.1.1.1. Gene Synthesis market size and forecast, 2021-2031 (USD Million)
5.1.2. Genome Engineering
5.1.2.1. Genome Engineering market size and forecast, 2021-2031 (USD Million)
5.1.3. Sequencing
5.1.3.1. Sequencing Market size and forecast, 2021-2031 (USD Million)
5.1.4. Bioinformatics
5.1.4.1. Bioinformatics Market size and forecast, 2021-2031 (USD Million)
5.1.5. Cloning
5.1.5.1. Cloning Market size and forecast, 2021-2031 (USD Million)
5.1.6. Site-Directed Mutagenesis
5.1.6.1. Site-Directed Mutagenesis size and forecast, 2021-2031 (USD Million)
5.1.7. Measurement & Modeling
5.1.7.1. Measurement & Modeling market size and forecast, 2021-2031 (USD Million)
5.1.8. Microfluidics
5.1.8.1. microfluidics market size and forecast, 2021-2031 (USD Million)
5.1.9. Nanotechnology
5.1.9.1. nanotechnology market size and forecast, 2021-2031 (USD Million)
5.1.10. Others
5.1.10.1. Others market size and forecast, 2021-2031 (USD Million)
6. Global Synthetic Biology Market Analysis and Forecast, 2021-2031 By Patient Demographics (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Geriatric
6.1.1.1. Geriatric market size and forecast, 2021-2031 (USD Million)
6.1.2. Adult
6.1.2.1. Adult market size and forecast, 2021-2031 (USD Million)
6.1.3. Pediatric
6.1.3.1. Pediatric market size and forecast, 2021-2031 (USD Million)
7. Global Synthetic Biology Market Analysis and Forecast, 2021-2031 By Application (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Medical Applications
7.1.1.1. Medical Applications market size and forecast, 2021-2031 (USD Million)
7.1.2. Pharmaceuticals
7.1.2.1. Pharmaceuticals market size and forecast, 2021-2031 (USD Million)
7.1.3. Industrial Applications
7.1.3.1. Industrial Applications market size and forecast, 2021-2031 (USD Million)
7.1.4. Food & Agriculture
7.1.4.1. Food & Agriculture market size and forecast, 2021-2031 (USD Million)
7.1.5. Environmental Applications
7.1.5.1. Environmental Applications market size and forecast, 2021-2031 (USD Million)
7.1.6. Others
7.1.6.1. Others market size and forecast, 2021-2031 (USD Million)
8. Global Synthetic Biology Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Direct Tender
8.1.1.1. Direct Tender market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Sales
8.1.2.1. Retail Sales market size and forecast, 2021-2031 (USD Million)
9. North America Synthetic Biology Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Synthetic Biology Market Size and Forecast By Product Type
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Synthetic Biology Market Size and Forecast By Technology
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Synthetic Biology Market Size and Forecast By Application
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Synthetic Biology Market Size and Forecast By Patient Demographics
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Synthetic Biology Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Synthetic Biology Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Synthetic Biology Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Synthetic Biology Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Synthetic Biology Market Size and Forecast By Product Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Synthetic Biology Market Size and Forecast By Technology
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Synthetic Biology Market Size and Forecast By Patient Demographics
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Synthetic Biology Market Size and Forecast By Application
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Synthetic Biology Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Synthetic Biology Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Synthetic Biology Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Synthetic Biology Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Synthetic Biology Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Synthetic Biology Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Synthetic Biology Market Size and Forecast By Product Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Synthetic Biology Market Size and Forecast By Technology
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Synthetic Biology Market Size and Forecast By Patient Demographics
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Synthetic Biology Market Size and Forecast By Application
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Synthetic Biology Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Synthetic Biology Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Synthetic Biology Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Synthetic Biology Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Synthetic Biology Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Synthetic Biology Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Synthetic Biology Market Size and Forecast By Product Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Synthetic Biology Market Size and Forecast By Technology
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Synthetic Biology Market Size and Forecast By Patient Demographics
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Synthetic Biology Market Size and Forecast By Application
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Synthetic Biology Market Size and Forecast By Distribution Channel
12.7. Brazil Synthetic Biology Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Synthetic Biology Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Synthetic Biology Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Synthetic Biology Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Synthetic Biology Market Size and Forecast By Product Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Synthetic Biology Market Size and Forecast By Technology
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Synthetic Biology Market Size and Forecast By Patient Demographics
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Synthetic Biology Market Size and Forecast By Application
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Synthetic Biology Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Synthetic Biology Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Synthetic Biology Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Synthetic Biology Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Synthetic Biology Market
14.1. Thermo Fisher Scientific, Inc.
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Merck Kgaa
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. Agilent Technologies, Inc.
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. Novozymes A/S
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. GINKGO BIOWORKS
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. Amyris, Inc.
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Intrexon Corporation
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. Genscript Biotech Corporation
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Twist Bioscience
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. Synthetic Genomics, Inc. (SGI)
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Synthetic Biology Market Drivers & Restraints 2021
Table 7. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 123. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 128. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 133. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 138. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 143. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 148. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 153. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 158. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 163. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 168. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 173. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 178. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 183. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 187. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 228. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 233. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 234. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 235. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 236. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 237. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 238. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 239. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 240. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 241. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 242. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 243. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 244. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 245. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 246. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 247. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 248. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 249. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 250. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 251. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 252. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 362. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 363. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 364. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 365. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 366. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 367. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 368. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 369. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 370. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 371. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 372. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 373. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 374. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 375. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 376. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 377. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 378. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 379. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 380. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 381. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 382. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 383. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 384. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 385. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 386. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 387. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 388. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 389. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 390. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 391. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 392. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 393. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 394. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 395. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 396. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 397. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 398. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 399. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 400. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 401. Leading 10 Synthetic Biology Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 402. Thermo Fisher Scientific, Inc.Profile 2019 (CEO, HQ, Founded, Website)
Table 403. Thermo Fisher Scientific, Inc. Synthetic Biology Product Offering (Segment, Product Offerings)
Table 404. Merck Kgaa Profile 2019 (CEO, HQ, Founded, Website)
Table 405. Merck Kgaa Synthetic Biology Product Offering (Segment, Product Offerings)
Table 406. Agilent Technologies, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 407. Agilent Technologies, Inc..Synthetic Biology Product Offering (Segment, Product Offerings)
Table 408. Novozymes A/S Profile 2019 (CEO, HQ, Founded, Website)
Table 409. Novozymes A/S Synthetic Biology Product Offering (Segment, Product Offerings)
Table 410. GINKGO BIOWORKS Profile 2019 (CEO, HQ, Founded, Website)
Table 411. GINKGO BIOWORKS Synthetic Biology Product Offering (Segment, Product Offerings)
Table 412. Amyris, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 413. Amyris, Inc. Synthetic Biology Product Offering (Segment, Product Offerings)
Table 414. Intrexon Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 415. Intrexon Corporation Synthetic Biology Product Offering (Segment, Product Offerings)
Table 416. Genscript Biotech Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 417. Genscript Biotech Corporation Synthetic Biology Product Offering (Segment, Product Offerings)
Table 418. Twist Bioscience Profile 2019 (CEO, HQ, Founded, Website)
Table 419. Twist Bioscience Synthetic Biology Product Offering (Segment, Product Offerings)
Table 420. Synthetic Genomics, Inc. (SGI) Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 421. Synthetic Genomics, Inc. (SGI) Synthetic Biology Product Offering (Segment, Product Offerings)
Table 422. Other Companies Involved in the Synthetic Biology Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Synthetic Biology Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Synthetic Biology Market Drivers & Restraints 2021
Figure 7. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Oligonucleotides Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Enzymes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Cloning Technology Kits Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Synthetic Cells Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Synthetic Genes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Synthetic DNA Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Synthetic Clones Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Chassis Organisms Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Xeno-Nucleic Acids Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Synthetic Biology Market Forecast By Technology 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Gene Synthesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Genome Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Sequencing Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Bioinformatics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Cloning Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Site-Directed Mutagenesis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Measurement & Modeling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 118. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 123. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 128. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. Adult Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 133. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 138. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. Synthetic Biology Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 143. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. Industrial Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 148. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. Medical Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 153. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. Pharmaceuticals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 158. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. Food & Agriculture Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 163. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. Environmental Applications Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 168. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 173. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 178. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 183. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. North America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. North America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. North America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 203. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 204. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 205. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 206. North America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 207. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 208. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 209. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 210. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 211. North America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 212. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 213. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 214. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 215. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 216. North America Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 217. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 218. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 219. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 220. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 221. US Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 222. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 223. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 224. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 225. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 226. Canada Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 227. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 228. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 229. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 230. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 231. Europe Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 232. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 233. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 234. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 235. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 236. Europe Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 237. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 238. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 239. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 240. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 241. Europe Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 242. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 243. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 244. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 245. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 246. Europe Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 247. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 248. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 249. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 250. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 251. Europe Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 252. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Europe Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. UK Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Germany Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. France Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. Rest of Europe Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. Asia Pacific Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Asia Pacific Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. Asia Pacific Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. Asia Pacific Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Asia Pacific Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Asia Pacific Synthetic Biology Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. China Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. India Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Japan Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. RoAPAC Synthetic Biology Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Middle East Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Middle East Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Middle East Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Middle East Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Middle East Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Latin America Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Latin America Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 362. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 363. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 364. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 365. Latin America Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 366. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 367. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 368. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 369. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 370. Latin America Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 371. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 372. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 373. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 374. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 375. Latin America Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 376. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 377. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 378. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 379. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 380. Africa Synthetic Biology Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 381. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 382. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 383. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 384. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 385. Africa Synthetic Biology Market Forecast By Technology 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 386. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 387. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 388. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 389. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 390. Africa Synthetic Biology Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 391. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 392. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 393. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 394. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 395. Africa Synthetic Biology Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 396. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 397. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 398. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 399. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 400. Africa Synthetic Biology Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 401. Porter’s Five Force Analysis
Companies Mentioned
1. Synthetic Genomics, Inc. (SGI)
2. Codexis, Inc.
3. Synthego Corporation
4. Creative Enzymes
5. Eurofins Scientific
6. Cyrus Biotechnology, Inc.
7. GlaxoSmithKline PLC
8. Biomarin Pharmaceutical Inc
9. Grifols SA
10. UCB SA
11. Eisai Co Ltd
12. Novo Nordisk A/S
13. Alexion Pharmaceuticals Inc
14. Takeda Pharmaceutical Co Ltd
15. Chugai Pharmaceutical Co Ltd
16. Perrigo Company PLC
17. Astellas Pharma Inc
18. Mitsubishi Tanabe Pharma Corp
19. Johnson & Johnson
20. Shanghai Fosun Pharmaceutical Group Co Ltd
21. Jiangsu Hengrui Medicine Co Ltd
22. Allergan plc
23. Shire PLC
24. Kyowa Hakko Kirin Co Ltd
25. Pfizer Inc
26. Taisho Pharmaceutical Holdings Co Ltd
27. MYL.O
28. Zoetis Inc
29. Bristol-Myers Squibb Co
30. Merck & Co Inc
31. AbbVie Inc
32. Jazz Pharmaceuticals PLC
33. Sumitomo Dainippon Pharma Co Ltd
34. AstraZeneca PLC
35. China Grand Automotive Services Co Ltd
36. Daiichi Sankyo Co Ltd
37. Novartis AG
38. Tasly Pharmaceutical Group Co Ltd
39. CSL Ltd
40. Biogen Inc
41. Orion Oyj
42. Bayer AG
43. CSPC Pharmaceutical Group Ltd
44. Sanofi SA
45. Roche Holding AG
46. Ono Pharmaceutical Co Ltd
47. Beijing Tongrentang Co Ltd
48. Kangmei Pharmaceutical Co Ltd
49. Ipsen SA
50. Abbott Laboratories
51. Shionogi & Co Ltd
52. Eli Lilly and Co
53. Recordati Industria Chimica e Farmaceutica SpA
54. Hikma Pharmaceuticals PLC
55. Teva Pharmaceutical Industries Ltd
56. Merck KGaA
Companies Profiled in the Report
1. Thermo Fisher Scientific, Inc.
2. Merck Kgaa
3. Agilent Technologies, Inc.
4. Novozymes A/S
5. Ginkgo Bioworks
6. Amyris, Inc.
7. Intrexon Corporation
8. Genscript Biotech Corporation
9. Twist Bioscience
List of Companies Mentioned in the Report:
1. Synthetic Genomics, Inc. (SGI)
2. Codexis, Inc.
3. Synthego Corporation
4. Creative Enzymes
5. Eurofins Scientific
6. Cyrus Biotechnology, Inc.
7. GlaxoSmithKline PLC
8. Biomarin Pharmaceutical Inc
9. Grifols SA
10. UCB SA
11. Eisai Co Ltd
12. Novo Nordisk A/S
13. Alexion Pharmaceuticals Inc
14. Takeda Pharmaceutical Co Ltd
15. Chugai Pharmaceutical Co Ltd
16. Perrigo Company PLC
17. Astellas Pharma Inc
18. Mitsubishi Tanabe Pharma Corp
19. Johnson & Johnson
20. Shanghai Fosun Pharmaceutical Group Co Ltd
21. Jiangsu Hengrui Medicine Co Ltd
22. Allergan plc
23. Shire PLC
24. Kyowa Hakko Kirin Co Ltd
25. Pfizer Inc
26. Taisho Pharmaceutical Holdings Co Ltd
27. MYL.O
28. Zoetis Inc
29. Bristol-Myers Squibb Co
30. Merck & Co Inc
31. AbbVie Inc
32. Jazz Pharmaceuticals PLC
33. Sumitomo Dainippon Pharma Co Ltd
34. AstraZeneca PLC
35. China Grand Automotive Services Co Ltd
36. Daiichi Sankyo Co Ltd
37. Novartis AG
38. Tasly Pharmaceutical Group Co Ltd
39. CSL Ltd
40. Biogen Inc
41. Orion Oyj
42. Bayer AG
43. CSPC Pharmaceutical Group Ltd
44. Sanofi SA
45. Roche Holding AG
46. Ono Pharmaceutical Co Ltd
47. Beijing Tongrentang Co Ltd
48. Kangmei Pharmaceutical Co Ltd
49. Ipsen SA
50. Abbott Laboratories
51. Shionogi & Co Ltd
52. Eli Lilly and Co
53. Recordati Industria Chimica e Farmaceutica SpA
54. Hikma Pharmaceuticals PLC
55. Teva Pharmaceutical Industries Ltd
56. Merck KGaA
List of Organizations Mentioned in the Report:
1. Centre for Pharmaceutical Administration Health Sciences Authority
2. Central Drug Standard Control Organization (CDSCO)
3. Organisation for Economic Co-operation and Development (OECD)
4. European Medicines Agency (EMA)
5. Food and Drug Administration (FDA)
6. National Institutes of Health (NIH)
7. United Nations (UN)
8. United Nations Office on Drugs and Crime (UNODC)
9. United Nations Statistics Division (UNSD)
10. Statistical Office of the European Union (EUROSTAT)
11. University of Connecticut
12. World Health Organization (WHO)
13. The National Medical Products Administration (NMPA)
14. Indian Council of Medical Research (ICMR)
15. The Therapeutic Goods Administration
16. The Federal Institute for Drugs and Medical Devices (BfArM)
17. Pharmaceuticals and Medical Devices Agency (PMDA)
18. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
19. Ministry of Health, Labour & Welfare(MHLW)
20. Medicines and Healthcare Products Regulatory Agency (MHRA)
1. Thermo Fisher Scientific, Inc.
2. Merck Kgaa
3. Agilent Technologies, Inc.
4. Novozymes A/S
5. Ginkgo Bioworks
6. Amyris, Inc.
7. Intrexon Corporation
8. Genscript Biotech Corporation
9. Twist Bioscience
List of Companies Mentioned in the Report:
1. Synthetic Genomics, Inc. (SGI)
2. Codexis, Inc.
3. Synthego Corporation
4. Creative Enzymes
5. Eurofins Scientific
6. Cyrus Biotechnology, Inc.
7. GlaxoSmithKline PLC
8. Biomarin Pharmaceutical Inc
9. Grifols SA
10. UCB SA
11. Eisai Co Ltd
12. Novo Nordisk A/S
13. Alexion Pharmaceuticals Inc
14. Takeda Pharmaceutical Co Ltd
15. Chugai Pharmaceutical Co Ltd
16. Perrigo Company PLC
17. Astellas Pharma Inc
18. Mitsubishi Tanabe Pharma Corp
19. Johnson & Johnson
20. Shanghai Fosun Pharmaceutical Group Co Ltd
21. Jiangsu Hengrui Medicine Co Ltd
22. Allergan plc
23. Shire PLC
24. Kyowa Hakko Kirin Co Ltd
25. Pfizer Inc
26. Taisho Pharmaceutical Holdings Co Ltd
27. MYL.O
28. Zoetis Inc
29. Bristol-Myers Squibb Co
30. Merck & Co Inc
31. AbbVie Inc
32. Jazz Pharmaceuticals PLC
33. Sumitomo Dainippon Pharma Co Ltd
34. AstraZeneca PLC
35. China Grand Automotive Services Co Ltd
36. Daiichi Sankyo Co Ltd
37. Novartis AG
38. Tasly Pharmaceutical Group Co Ltd
39. CSL Ltd
40. Biogen Inc
41. Orion Oyj
42. Bayer AG
43. CSPC Pharmaceutical Group Ltd
44. Sanofi SA
45. Roche Holding AG
46. Ono Pharmaceutical Co Ltd
47. Beijing Tongrentang Co Ltd
48. Kangmei Pharmaceutical Co Ltd
49. Ipsen SA
50. Abbott Laboratories
51. Shionogi & Co Ltd
52. Eli Lilly and Co
53. Recordati Industria Chimica e Farmaceutica SpA
54. Hikma Pharmaceuticals PLC
55. Teva Pharmaceutical Industries Ltd
56. Merck KGaA
List of Organizations Mentioned in the Report:
1. Centre for Pharmaceutical Administration Health Sciences Authority
2. Central Drug Standard Control Organization (CDSCO)
3. Organisation for Economic Co-operation and Development (OECD)
4. European Medicines Agency (EMA)
5. Food and Drug Administration (FDA)
6. National Institutes of Health (NIH)
7. United Nations (UN)
8. United Nations Office on Drugs and Crime (UNODC)
9. United Nations Statistics Division (UNSD)
10. Statistical Office of the European Union (EUROSTAT)
11. University of Connecticut
12. World Health Organization (WHO)
13. The National Medical Products Administration (NMPA)
14. Indian Council of Medical Research (ICMR)
15. The Therapeutic Goods Administration
16. The Federal Institute for Drugs and Medical Devices (BfArM)
17. Pharmaceuticals and Medical Devices Agency (PMDA)
18. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
19. Ministry of Health, Labour & Welfare(MHLW)
20. Medicines and Healthcare Products Regulatory Agency (MHRA)
Download sample pages
Complete the form below to download your free sample pages for Synthetic Biology Market Report 2021-2031Download sample pages
Complete the form below to download your free sample pages for Synthetic Biology Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Would you like to get the latest Visiongain pharma reports catalogue?
What are the dynamic growth sectors? where are the regional business opportunities?
Which technologies will prevail and who are the leading companies succeeding in these sectors and why?
If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports.
If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.Click here to ‘Like’ our Facebook page https://www.facebook.com/V.G.Pharma/
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031
Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.
11 October 2021
Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031
High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.
07 October 2021
Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031
Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.
06 October 2021
Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031
Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market
05 October 2021
